List of works - Ali Naderi

A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes

scientific article

A Feedback Loop between Androgen Receptor and ERK Signaling in Estrogen Receptor-Negative Breast Cancer ⬇️

scientific article published on February 1, 2011

A consensus prognostic gene expression classifier for ER positive breast cancer

scientific article published on 31 October 2006

A feedback loop between BEX2 and ErbB2 mediated by c-Jun signaling in breast cancer

scientific article published on 20 April 2011

A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer.

scientific article published on June 2008

A gene-expression signature to predict survival in breast cancer across independent data sets.

scientific article

Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line

scientific article

BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer

scientific article

BEX2 is overexpressed in a subset of primary breast cancers and mediates nerve growth factor/nuclear factor-kappaB inhibition of apoptosis in breast cancer cell lines

scientific article

BEX2 regulates mitochondrial apoptosis and G1 cell cycle in breast cancer

scientific article published in April 2010

BRCA2 and pancreatic cancer

scientific article

C1orf64 is a novel androgen receptor target gene and coregulator that interacts with 14-3-3 protein in breast cancer.

scientific article published on 11 May 2017

Coagulation factor VII is regulated by androgen receptor in breast cancer

scientific article

Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancer

scientific article

Expression microarray reproducibility is improved by optimising purification steps in RNA amplification and labelling

scientific article

Genomic and epigenetic aberrations of chromosome 1p36.13 have prognostic implications in malignancies

scientific article published on 20 August 2020

Inhibition of androgen receptor and Cdc25A phosphatase as a combination targeted therapy in molecular apocrine breast cancer.

scientific article published on 6 July 2010

Microdeletion of 22q11.1 is associated with two cases of familial nonsyndromic basal cell carcinoma.

scientific article

Molecular functions of brain expressed X-linked 2 (BEX2) in malignancies

scientific article published on 16 February 2019

Nerve growth factor/nuclear factor-kappaB pathway as a therapeutic target in breast cancer.

scientific article

Optimal Amounts of Fluorescent Dye Improve Expression Microarray Results in Tumor Specimens

scientific article published on 01 June 2005

PACK: Profile Analysis using Clustering and Kurtosis to find molecular classifiers in cancer

scientific article

Prolactin-Induced Protein regulates cell adhesion in breast cancer

scientific article published on 13 November 2015

Prolactin-induced protein in breast cancer.

scientific article

Prolactin-induced protein is required for cell cycle progression in breast cancer.

scientific article

Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancer

scientific article

SRARP and HSPB7 are epigenetically regulated gene pairs that function as tumor suppressors and predict clinical outcome in malignancies.

scientific article

Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies

scientific article published on 24 July 2020

Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer

scientific article published on April 2011

TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors

scientific article published on 01 July 2002

The 17q23 amplicon and breast cancer

scientific article

Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers.

scientific article published on 25 September 2006

List of works by Ali Naderi

A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes

A Feedback Loop between Androgen Receptor and ERK Signaling in Estrogen Receptor-Negative Breast Cancer ⬇️

A consensus prognostic gene expression classifier for ER positive breast cancer

A feedback loop between BEX2 and ErbB2 mediated by c-Jun signaling in breast cancer

A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer.

A gene-expression signature to predict survival in breast cancer across independent data sets.

Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line

BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer

BEX2 is overexpressed in a subset of primary breast cancers and mediates nerve growth factor/nuclear factor-kappaB inhibition of apoptosis in breast cancer cell lines

BEX2 regulates mitochondrial apoptosis and G1 cell cycle in breast cancer

BRCA2 and pancreatic cancer

C1orf64 is a novel androgen receptor target gene and coregulator that interacts with 14-3-3 protein in breast cancer.

Coagulation factor VII is regulated by androgen receptor in breast cancer

Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancer

Expression microarray reproducibility is improved by optimising purification steps in RNA amplification and labelling

Genomic and epigenetic aberrations of chromosome 1p36.13 have prognostic implications in malignancies

Inhibition of androgen receptor and Cdc25A phosphatase as a combination targeted therapy in molecular apocrine breast cancer.

Microdeletion of 22q11.1 is associated with two cases of familial nonsyndromic basal cell carcinoma.

Molecular functions of brain expressed X-linked 2 (BEX2) in malignancies

Nerve growth factor/nuclear factor-kappaB pathway as a therapeutic target in breast cancer.

Optimal Amounts of Fluorescent Dye Improve Expression Microarray Results in Tumor Specimens

PACK: Profile Analysis using Clustering and Kurtosis to find molecular classifiers in cancer

Prolactin-Induced Protein regulates cell adhesion in breast cancer

Prolactin-induced protein in breast cancer.

Prolactin-induced protein is required for cell cycle progression in breast cancer.

Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancer

SRARP and HSPB7 are epigenetically regulated gene pairs that function as tumor suppressors and predict clinical outcome in malignancies.

Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies

Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer

TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors

The 17q23 amplicon and breast cancer

Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers.